(Reuters) - Sun Pharmaceutical Industries Ltd, India's largest drugmaker by market value, posted a nearly four-fold jump in quarterly profit on Tuesday, beating estimates.
Net profit came in at 12.42 billion rupees ($175.45 million) versus 3.22 billion rupees profit last year, the company said https://www.bseindia.com/xml-data/corpfiling/AttachLive/9819cff8-5ecb-48f5-8e0d-07f5ea16c25c.pdf.
This was above an average estimate for a profit of 9.86 billion rupees from 16 analysts, Refinitiv Eikon data shows.
Last year in the same quarter the company had a one-time tax expense of 5.13 billion rupees.
Total revenue from operations grew 16.3 percent to 77.40 billion rupees.
(Reporting by Krishna V Kurup in Bengaluru; Editing by David Evans)
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)